The Effects of Finasteride on Apoptosis, Antioxidants, and Cytokines in Experimental Diabetes Rats
Journal of Applied Toxicology · 2025
DOI: 10.1002/jat.4823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2025. Verfasst von Dilek Aksit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Sciences, Faculty of Engineering and Natural Sciences, Kütahya Health Sciences University, Kütahya, Turkey. Hauptthemen laut MEDLINE: Finasteride, Apoptosis, Diabetes Mellitus, Experimental, Antioxidants. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Balikesir Üniversitesi.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) is one of the five leading causes of death worldwide. Finasteride is an inhibitor of type 2 5‐alpha reductase enzyme. In this study, we aimed to investigate the effects of finasteride on apoptosis, oxidative stress, antioxidants, and cytokines in the liver, kidney, and testis in an experimental diabetes model in rats. Thirty‐two male rats were randomly divided into four equal groups as follows: control, finasteride (30 mg/kg 14 days by gastric gavage), diabetes, and diabetes+finasteride. Malondialdehyde (MDA), superoxide dismutase (SOD), and total antioxidant status (TAS) levels in liver, kidney, and testis tissues, and nitric oxide (NO), interleukin 6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) levels in blood samples were examined. In addition, tissue sections were evaluated immunohistochemically (B‐cell lymphoma 2 (Bcl‐2), Bcl‐2 associated X protein (Bax)) and histopathologically. Induction of diabetes with streptozotocin resulted in an increase MDA, NO, IL‐6, TNF‐α levels whereas TAS and SOD decreased compared to the control group. Diabetes+Finasteride group was compared with the diabetes group decrease in MDA, NO, IL‐6, TNF‐α levels, and increase in TAS and SOD levels were observed. Finasteride suppressed apoptosis through the down regulation of Bax and the induction of the expression of Bcl‐2 in the liver and kidney. Finasteride administration ameliorated some histopathological changes and decreased oxidative stress, apoptosis, and inflammation while increasing the antioxidant defense system in the STZ‐induced diabetes group. In conclusion, finasteride might show a protective effect by suppressing oxidative stress and apoptosis and downregulation of proinflammatory cytokines in diabetic rats with its antioxidant and antiapoptotic effects. Human trials are needed before clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Forensic Sciences, Faculty of Engineering and Natural Sciences, Kütahya Health Sciences University, Kütahya, Turkey.
- Department of Pathology, University of Health Sciences, Bagcilar Training and Research Hospital, Istanbul, Turkey.
- Department of Veterinary, Savastepe Vocational School, University of Balikesir, Balikesir, Turkey.
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Balikesir, Balikesir, Turkey.
- Department of Basic Sciences, Faculty of Engineering and Natural Sciences, Kütahya Health Sciences University, Kütahya, Turkey.
ORCID-Profile: Dilek Aksit, Eren Altun, Murat Celebi, Cagla Celebi, Hasan Aksit
Förderung
- Balikesir Üniversitesi
Zitieren
APA
Aksit, D., Altun, E., Celebi, M., Celebi, C., & Aksit, H. (2025). The Effects of Finasteride on Apoptosis, Antioxidants, and Cytokines in Experimental Diabetes Rats. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4823
Vancouver
Aksit D, Altun E, Celebi M, Celebi C, Aksit H. The Effects of Finasteride on Apoptosis, Antioxidants, and Cytokines in Experimental Diabetes Rats. Journal of Applied Toxicology. 2025. doi:10.1002/jat.4823
BibTeX
@article{Aksit2025,
author = {Aksit, Dilek and Altun, Eren and Celebi, Murat and Celebi, Cagla and Aksit, Hasan},
title = {The Effects of Finasteride on Apoptosis, Antioxidants, and Cytokines in Experimental Diabetes Rats},
journal = {Journal of Applied Toxicology},
year = {2025},
doi = {10.1002/jat.4823}
}
EUVIMED